Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma.
biomarkers
diagnosis
microRNAs
pancreatic ductal adenocarcinoma
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
18 Feb 2024
18 Feb 2024
Historique:
received:
30
12
2023
revised:
12
02
2024
accepted:
14
02
2024
medline:
24
2
2024
pubmed:
24
2
2024
entrez:
24
2
2024
Statut:
epublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC), a neoplasm of the gastrointestinal tract, is the most common pancreatic malignancy (90%) and the fourth highest cause of cancer mortality worldwide. Surgery intervention is currently the only strategy able to offer an advantage in terms of overall survival, but prognosis remains poor even for operated patients. Therefore, the development of robust biomarkers for early diagnosis and prognostic stratification in clinical practice is urgently needed. In this work, we investigated deregulated microRNAs (miRNAs) in tissues from PDAC patients with high (G3) or low (G2) histological grade and with (N+) or without (N-) lymph node metastases. miRNA expression profiling was performed by a comprehensive PCR array and subsequent validation by RT-qPCR. The results showed a significant increase in miR-1-3p, miR-31-5p, and miR-205-5p expression in G3 compared to G2 patients (**
Identifiants
pubmed: 38398215
pii: cancers16040824
doi: 10.3390/cancers16040824
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Campania L. Vanvitelli through the grant VALERE
ID : GO MAGIC
Organisme : Ministero Italiano per lo Sviluppo Economico (MISE)
ID : Epi-Met